InterWest News
Medtech Insight and Windhover Information's 2006
Investment in Innovation (In3) East Conference
A Preview of Early-Stage Medical Technology Companies
October 3-5, 2007
Westin Copley Place, Boston, MA
June 13, 2007 — NORWALK, Conn. (BUSINESS WIRE) The 2007 Investment in Innovation (In3) East Conference, sponsored by Medtech Insight, a division of Windhover Information, is gearing up to be the most exclusive medtech partnering event ever, thanks to its Advisory Board of top VCs.
In3 East is the largest East Coast strategic partnership and investment meeting for medical technology executives. The In3 East Advisory Board will hand-select every presenting company, ensuring the highest-quality presenter agenda and drawing top-level medical technology executives, venture capitalists and investors.
The In3 East Advisory Board includes:
- Jeffrey Barnes
General Partner, Oxford Bioscience Partners
- Michael Carusi
General Partner, Advanced Technology Ventures
- William T. Harrington
Partner, Three Arch Partners
- Ellen Koskinas
Partner, InterWest Partners
- Josh Makower
Venture Partner, NEA
- David Milne
Managing Partner, SC Life Science Advisers
- Annette Campbell-White
Senior Managing Member, MedVenture Associates
- Richard M. Ferrari
Managing Director, DeNovo Ventures
- John Maroney
General Partner, Delphi Ventures
- Ross A. Jaffe
Managing Director, Versant Ventures
Executives who attend In3 East include presidents; CEOs; chairmen; venture partners; managing directors; vice presidents/directors of business development, marketing, new technology, acquisitions, R & D & sales; and senior investment analysts/managers/directors.
Windhover is offering a savings of $300 off registrations made by July 1, 2007. Information and registration is available at www.medtechinsight.com.
Covering the most dynamic spaces in medical technology
Hundreds of venture capital and medical technology companies gather at In3 East every year to hear about the latest innovations and investment opportunities, especially in the following areas:
- Cardiovascular/interventional cardiology
- Diagnostics
- Drug delivery
- Imaging
- Minimally invasive surgery
- Nanotechnology
- Neurostimulation
- Orthopedics/spine
- Peripheral vascular
- Stem cells
- Stroke management
- Wound management
... among many other high-growth areas.
More than 50 companies with exciting new technologies will present, seeking funding and/or strategic partnership. These companies will provide 10-minute overviews by a senior executive from each company, followed by the opportunity to meet one-on-one in private breakout rooms.
Past presenting companies include Bioconnect Systems, Biomedix, Immunocept, Inovise Medical, NovoStent Corp., Pathway Medical Technologies, PreSRV, Stentys, TheraCyte Inc. and Victhom Human Bionics.
In3 East attendees will include established medical technology companies seeking technology through licensing, partnering and acquisition to broaden or deepen product lines or build sector strength; venture capitalists and investment bankers; and medical device, biotech, biopharmaceutical or other company executives seeking investments or partnerships.
Past attendees have included 3M, Abbott Laboratories, Aberdare Ventures, Abingworth Management Ltd., ABN AMRO Inc., Accuitive Medical Ventures, Advanced Technology Ventures (ATV), Affinity Capital Management, American Medical Systems, Baird Venture Partners, Bard Electrophysiology Division, Baxter Healthcare, Bay City Capital Partners LLC, Bayer Innovation GmbH, Becton Dickinson, Blackstone Medical Inc., Bonecraft Inc., Boston Equities, Boston Medical Technologies Inc., Boston Scientific, Bristol-Myers Squibb, Medical Imaging Inc., BTG International Inc., C.R. Bard Inc., California Technology Ventures, Canaan Partners, Canaccord Adams, Cardinal Health, CIBC World Markets Corp., CID Equity Partners, Commons Capital, Cook Group Inc., Cordis / Johnson & Johnson Medical, Cytyc Development Corp., DePuy Spine - Europe, Middle East & Africa (EMEA), DSM New Business Development, Earlybird Ventures, Edwards Lifesciences Corp., Edwards Lifesciences Europe, EGS Healthcare Capital Partners LLC, Eli Lilly & Co., Elliott Investments, Ethicon Endo-Surgery Inc., FoxHollow Technologies Inc., Frantz Medical Ventures, Galen Associates, GE Healthcare Financial Services, Golden Gate Capital, Guidant, Hologic Inc., Kairos Partners LP, Kaiser Permanente Ventures, Karolinska Investment Fund, Kearny Venture Partners, KeyBanc Capital Markets, Kimberly-Clark Health Care, Kobayashi Pharmaceuticals Co. Inc., KPMG Corporate Finance LLC, Krauth Medical K, Kyphon Inc., LaunchCyte LLC, Life Science Angels, Maverick Capital, MB Venture Partners, MedFocus Fund LLC, Medical Device Ventures LLC, Medical Value Partners LLC, Medtech Ventures, Medtronic, Monitor Ventures, Morgan Stanley Venture Partners, Morgenthaler Ventures, MPM Capital, New Leaf Venture Partners, NIF SMBC Ventures, Nova MedVentures, Novartis BioVenture Fund, Novartis Pharmaceuticals Corp., Olympus America Inc., Orbimed Advisors, Oxford Bioscience Partner, Pacific Venture Group, Palo Alto Capital Partners LLC, Panorama Capita, Pathfinder Venture, Pequot Capital Management Inc., Peregrine Ventures, Pharos Capital Group, Philips Medical Systems, Phytis Medical Devices GmbH, Pinnacle Ventures LLC, Pitango Venture Capital, Polaris Venture Partners, Primus Venture Partners Inc., Prospect Venture Partners, SD Tech Coast Angels, Smith & Nephew, Sofinnova Partners, Spray Venture Partners, St. Jude, Stryker - Europe, Middle East & Africa (EMEA), SA, Stryker Corp., SV Life Sciences (SVLS), Techno Venture Management, Technology Funding Partners III LP, The Aurora Funds, The Blackstone Group, The Carlyle Group, The Foundry Inc., The Ofer Group, The Vertical Group, Three Arch Partners, Tyco Healthcare Group LP, UCSD Galen Capital, Versant Ventures, Wachovia Securities, Zimmer Inc. and many more. A list of past attending companies is available at www.medtechinsight.com/pastattendees.html.
Industry leaders to share their insights
Attendees at In3 East will network with peers who face similar challenges in regulatory, reimbursement and clinical issues for medical devices. Also offered at In3 East are ke ynote presentations and on-stage interviews with industry leaders; investment and financing panel discussions by prominent device industry executives; venture capital dealmaking presentations; buy side panels; and educational workshops for start-up companies.
The event is focused on helping attendees catch up on the state of medical technology investment and partnering; benchmark their dealmaking against the best and the brightest; find out which companies and technologies are worth the investment; get key trend analysis on medical technology deal structures; maximize their strategic alliance opportunities by meeting business development leaders who'll share practical advice and strategies on how to structure successful deals; and walk away with practical, real-life lessons from some of the most experienced dealmakers in the industry in the medical technology marketplace.
A must-attend event for thousands of executives
Windhover's conferences have drawn over 6,100 attendees and 700 innovative early-stage presenting companies over the past six years, making them the premier investment, partnering, and networking events in the medical technology industry.
This year's co-sponsors include 3i; AdvaMed; Battelle; Business Wire; Factory; Finnegan, Henderson, Farrabow, Garrett & Dunner; Medical Capital Advisors; Medmarc®, The Hartford, Ronald Trahan Associates; Teledyne Microelectronic Technologies; The MedTech Group Inc.; and Underwriters Laboratories Inc.
To attend this conference, you may register online at www.medtechinsight.com, or call 1.949.219.0150 or 888.290.2225 (toll-free in the U.S.), or e-mail sales@medtechinsight.com.
About Medtech Insight
Medtech Insight, a division of Windhover Information Inc., is the leading provider of business information and market intelligence for the medical technology marketplace. For more on the company's products and services, please see www.medtechinsight.com.